These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8134395)
1. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Winn SR; Hammang JP; Emerich DF; Lee A; Palmiter RD; Baetge EE Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2324-8. PubMed ID: 8134395 [TBL] [Abstract][Full Text] [Related]
2. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences. Winn SR; Lindner MD; Lee A; Haggett G; Francis JM; Emerich DF Exp Neurol; 1996 Aug; 140(2):126-38. PubMed ID: 8690056 [TBL] [Abstract][Full Text] [Related]
3. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Hoffman D; Breakefield XO; Short MP; Aebischer P Exp Neurol; 1993 Jul; 122(1):100-6. PubMed ID: 8339781 [TBL] [Abstract][Full Text] [Related]
4. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. Emerich DF; Winn SR; Harper J; Hammang JP; Baetge EE; Kordower JH J Comp Neurol; 1994 Nov; 349(1):148-64. PubMed ID: 7852623 [TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Mandel RJ; Gage FH; Clevenger DG; Spratt SK; Snyder RO; Leff SE Exp Neurol; 1999 Jan; 155(1):59-64. PubMed ID: 9918705 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. Shingo T; Date I; Yoshida H; Ohmoto T J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688 [TBL] [Abstract][Full Text] [Related]
7. Polymer-encapsulated Schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after a fimbria-fornix transection. Schinstine M; Fiore DM; Winn SR; Emerich DF Cell Transplant; 1995; 4(1):93-102. PubMed ID: 7728338 [TBL] [Abstract][Full Text] [Related]
8. Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons. Kordower JH; Chen EY; Mufson EJ; Winn SR; Emerich DF Neuroscience; 1996 May; 72(1):63-77. PubMed ID: 8730706 [TBL] [Abstract][Full Text] [Related]
9. Effect of nerve growth factor on the elongation of neurites from axotomized rat embryonic septal-basal forebrain neurons: an in vitro analysis. Schinstine M; Cornbrooks CJ J Neurosci Res; 1989 Aug; 23(4):371-83. PubMed ID: 2549266 [TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection. Otto D; Frotscher M; Unsicker K J Neurosci Res; 1989 Jan; 22(1):83-91. PubMed ID: 2926842 [TBL] [Abstract][Full Text] [Related]
11. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632 [TBL] [Abstract][Full Text] [Related]